Teladoc Health Inc (TDOC) Institutional Investor Snapshot (366 Funds, Q2 2026)

TDOC ranks #1700 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

TDOC is a disclosed holding of Steve Cohen (Point72 Asset Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.1% of that fund's own 13F portfolio.

366 institutions disclose a position in TDOC, but none treat it as a major bet — even Voss Capital, LP, its most concentrated holder, allocates just 3.4% of its own portfolio to it.

Counterpoint Mutual Funds LLC has added to its TDOC position for two straight quarters, increasing it by $9.0M to reach $9.6M today.

Essential Partners LLC has trimmed its TDOC position for two straight quarters, cutting it by $97.2K while still holding $15.6K.

TDOC is down 2.6% today, but institutions show net buying of $144.6M this quarter — a divergence between today's price move and the underlying institutional flow.

TDOC reported a net loss of $177.4M over the trailing twelve months.

• Not yet profitable — net loss of $177.4M over the trailing twelve months
• Revenue declined 2.1% year over year
• Net income improved year over year, from -$207.4M to -$177.4M
• Generated $294.4M in positive operating cash flow
• Current ratio of 2.77x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.06x equity — within a conventional range